Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15220)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 21, 2019 (publication date) through Oct 1, 2023
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ogunwobi OO, Harricharran T, Huaman J, Galuza A, Odumuwagun O, Tan Y, Ma GX, Nguyen MT. Mechanisms of hepatocellular carcinoma progression. World J Gastroenterol 2019; 25(19): 2279-2293 [PMID: 31148900 DOI: 10.3748/wjg.v25.i19.2279] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i19/2279.htm |
| Number | Citing Articles |
| 1 |
Lei Sun, Yaru Lin, Guichun Wang, Lin Zhang, Liangchang Hu, Zhong Lu. Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer. Bioscience Reports 2021; 41(1) doi: 10.1042/BSR20203115
|
| 2 |
Yih-Fung Chen, Ho-Cheng Wu, Jia-Min Chang, Horng-Huey Ko, Chu-Hung Lin, Hsun-Shuo Chang. Chemical investigations and cytotoxic effects of metabolites from Antrodia camphorata against human hepatocellular carcinoma cells. Natural Product Research 2023; 37(4): 560 doi: 10.1080/14786419.2022.2076676
|
| 3 |
Xianwu Yang, Xiaojuan Tian, Pengcheng Zhao, Zheng Wang, Xuedong Sun. Paclitaxel inhibits hepatocellular carcinoma tumorigenesis by regulating the circ_0005785/miR‐640/GSK3β. Cell Biology International 2023; 47(7): 1170 doi: 10.1002/cbin.11906
|
| 4 |
Heena B Choudhary, Satish K Mandlik, Deepa S Mandlik. Role of p53 suppression in the pathogenesis of hepatocellular carcinoma. World Journal of Gastrointestinal Pathophysiology 2023; 14(3): 46-70 doi: 10.4291/wjgp.v14.i3.46
|
| 5 |
Marwa A. Abdel-Wahed, Eman Mohamed Abdel Rahman Amer, Ramy Mohamed Mahmoud, Iman Fawzy Montasser, Yassmin M. Massoud, Perihan Hamdy, Safeya Hamdy Zakaria Hassan. CTNNB1 polymorphism (rs121913407) in circulating tumor DNA (ctDNA) in Egyptian hepatocellular carcinoma patients. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00204-0
|
| 6 |
Urvashi Vijay, Pranathi Pappu, Dhatri Madduru, Ngalah Bidii Stephen, Prashanth Suravajhala, Obul Reddy Bandapalli. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 293 doi: 10.1016/B978-0-323-98806-3.00008-8
|
| 7 |
Lok-Sze Wong, Chun-Ming Wong. Decoding the Roles of Long Noncoding RNAs in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(6): 3137 doi: 10.3390/ijms22063137
|
| 8 |
Shibambika Manna, Pragati Samal, Rohini Basak, Anushka Mitra, Arijit Kumar Roy, Raima Kundu, Amrita Ahir, Amlan Roychowdhury, Ditipriya Hazra. Amentoflavone and methyl hesperidin, novel lead molecules targeting epitranscriptomic modulator in acute myeloid leukemia: in silico drug screening and molecular dynamics simulation approach. Journal of Molecular Modeling 2023; 29(1) doi: 10.1007/s00894-022-05407-1
|
| 9 |
Jingjing Zhang, Xiaoxuan Ma, Daidi Fan. Ginsenoside CK Inhibits Hypoxia-Induced Epithelial–Mesenchymal Transformation through the HIF-1α/NF-κB Feedback Pathway in Hepatocellular Carcinoma. Foods 2021; 10(6): 1195 doi: 10.3390/foods10061195
|
| 10 |
Xiaowei Chang, Chang Tian, Yuanyuan Jia, Yu Cai, Pu Yan. MLXIPL promotes the migration, invasion, and glycolysis of hepatocellular carcinoma cells by phosphorylation of mTOR. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10652-5
|
| 11 |
Zhou-wei Xu, Na-na Liu, Xing-yu Wang, Bai-cheng Ding, Hai-feng Zhang, Ying Li, Wu-yi Sun, Wei Wei. Effect of PLC-β1/CaM signaling pathway mediated by AT1R on the occurrence and development of hepatocellular carcinoma. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02261-8
|
| 12 |
Liberatore Tramontano, Carlo Cavaliere, Marco Salvatore, Valentina Brancato. The Role of Non-Gaussian Models of Diffusion Weighted MRI in Hepatocellular Carcinoma: A Systematic Review. Journal of Clinical Medicine 2021; 10(12): 2641 doi: 10.3390/jcm10122641
|
| 13 |
Rui Huang, Lijun Zhang, Jinmei Jin, Yudong Zhou, Hongwei Zhang, Chao Lv, Dong Lu, Ye Wu, Hong Zhang, Sanhong Liu, Hongzhuan Chen, Xin Luan, Weidong Zhang. Bruceine D inhibits HIF-1α-mediated glucose metabolism in hepatocellular carcinoma by blocking ICAT/β-catenin interaction. Acta Pharmaceutica Sinica B 2021; 11(11): 3481 doi: 10.1016/j.apsb.2021.05.009
|
| 14 |
Wuyu Chen, Minghao Ruan, Minghao Zou, Fuchen Liu, Hui Liu. Clinical Significance of Non-Coding RNA Regulation of Programmed Cell Death in Hepatocellular Carcinoma. Cancers 2023; 15(16): 4187 doi: 10.3390/cancers15164187
|
| 15 |
Zilong Yan, Qingen Da, Zhangfu Li, Qirui Lin, Jing Yi, Yanze Su, Guanyin Yu, Qingqi Ren, Xu Liu, Zewei Lin, Jianhua Qu, Weihua Yin, Jikui Liu. Inhibition of NEK7 Suppressed Hepatocellular Carcinoma Progression by Mediating Cancer Cell Pyroptosis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.812655
|
| 16 |
Keisuke Fukuchi, Kayoko Nanai, Hiroshi Yuita, Chikako Maru, Jun Tsukada, Masato Ishigami, Yoko Nagai, Yoko Nakano, Chigusa Yoshimura, Kozo Yoneda, Masato Amano, Kensuke Nakamura, Yoko Oda, Haruyuki Nishigohri, Shoji Yamamoto, Yusuke Ohnishi-Totoki, Koichiro Inaki, Hironobu Komori, Rika Nakano, Yoshiyuki Kanari, Atsuko Nishida, Yumi Matsui, Satoko Funo, Sayako Takahashi, Toshiaki Ohtsuka, Toshinori Agatsuma, Shuanglin Qin. Novel Antibody Exerts Antitumor Effect through Downregulation of CD147 and Activation of Multiple Stress Signals. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/3552793
|
| 17 |
So Young Kim, Cheol Park, Min Yeong Kim, Seon Yeong Ji, Hyun Hwangbo, Hyesook Lee, Su Hyun Hong, Min Ho Han, Jin-Woo Jeong, Gi-Young Kim, Chang-Gue Son, JaeHun Cheong, Yung Hyun Choi. ROS-Mediated Anti-Tumor Effect of Coptidis Rhizoma against Human Hepatocellular Carcinoma Hep3B Cells and Xenografts. International Journal of Molecular Sciences 2021; 22(9): 4797 doi: 10.3390/ijms22094797
|
| 18 |
Arash Letafati, Sajad Najafi, Mehran Mottahedi, Mohammad Karimzadeh, Ali Shahini, Setareh Garousi, Mohammad Abbasi-Kolli, Javid Sadri Nahand, Seyed Saeed Tamehri Zadeh, Michael R. Hamblin, Neda Rahimian, Mohammad Taghizadieh, Hamed Mirzaei. MicroRNA let-7 and viral infections: focus on mechanisms of action. Cellular & Molecular Biology Letters 2022; 27(1) doi: 10.1186/s11658-022-00317-9
|
| 19 |
Munetoshi Akaoka, Koichiro Haruki, Tomohiko Taniai, Mitsuru Yanagaki, Yosuke Igarashi, Kenei Furukawa, Shinji Onda, Masashi Tsunematsu, Yoshihiro Shirai, Norimitsu Okui, Takeshi Gocho, Toru Ikegami. Clinical significance of cachexia index in patients with hepatocellular carcinoma after hepatic resection. Surgical Oncology 2022; 45: 101881 doi: 10.1016/j.suronc.2022.101881
|
| 20 |
Apichaya Khlaiphuengsin, Natthaya Chuaypen, Pimpayao Sodsai, Supranee Buranapraditkun, Tadech Boonpiyathad, Nattiya Hirankarn, Pisit Tangkijvanich. Decreased of BAFF-R expression and B cells maturation in patients with hepatitis B virus-related hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(20): 2645-2656 doi: 10.3748/wjg.v26.i20.2645
|
| 21 |
Saranya Chidambaranathan-Reghupaty, Paul B. Fisher, Devanand Sarkar. Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149: 1 doi: 10.1016/bs.acr.2020.10.001
|
| 22 |
Meritxell Perramón, Wladimiro Jiménez. Pituitary Tumor-Transforming Gene 1/Delta like Non-Canonical Notch Ligand 1 Signaling in Chronic Liver Diseases. International Journal of Molecular Sciences 2022; 23(13): 6897 doi: 10.3390/ijms23136897
|
| 23 |
Francisco Villalba-López, Luis Francisco Sáenz-Mateos, Maria Isabel Sánchez-Lorencio, Virginia De La Orden-García, Felipe Alconchel-Gago, Pedro Antonio Cascales-Campos, Carmen García-Bernardo, José Antonio Noguera-Velasco, Alberto Baroja-Mazo, Pablo Ramírez-Romero. Usefulness of PIVKA-II for monitoring after liver transplantation in patients with hepatocellular carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32879-9
|
| 24 |
Yue He, Wenqiang Tao, Chao Shang, Chan Qi, Dexiang Ji, Wei Lu, Guoan Chen. Xeroderma Pigmentosum group D suppresses proliferation and promotes apoptosis of HepG2 cells by downregulating ERG expression via the PPARγ pathway. International Journal of Experimental Pathology 2021; 102(3): 157 doi: 10.1111/iep.12396
|
| 25 |
An Li, Ning Wu, Jingyu Sun. E2F1‑induced microRNA‑224‑5p expression is associated with hepatocellular carcinoma cell migration, invasion and epithelial‑mesenchymal transition via MREG. Oncology Letters 2022; 23(3) doi: 10.3892/ol.2022.13202
|
| 26 |
Bufu Tang, Jinyu Zhu, Zhongwei Zhao, Chenying Lu, Siyu Liu, Shiji Fang, Liyun Zheng, Nannan Zhang, Minjiang Chen, Min Xu, Risheng Yu, Jiansong Ji. Diagnosis and prognosis models for hepatocellular carcinoma patient’s management based on tumor mutation burden. Journal of Advanced Research 2021; 33: 153 doi: 10.1016/j.jare.2021.01.018
|
| 27 |
Mariam Mroweh, Gaël Roth, Thomas Decaens, Patrice N. Marche, Hervé Lerat, Zuzana Macek Jílková. Targeting Akt in Hepatocellular Carcinoma and Its Tumor Microenvironment. International Journal of Molecular Sciences 2021; 22(4): 1794 doi: 10.3390/ijms22041794
|
| 28 |
Pelin BALÇIK ERÇİN. Integrative Analysis of SIX1 and Cancer Stem Cell Markers in Hepatocellular Carcinoma. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 2020; 7(3): 325 doi: 10.34087/cbusbed.689797
|
| 29 |
Koen C. van Son, Lars Verschuren, Roeland Hanemaaijer, Helen Reeves, R. Bart Takkenberg, Joost P. H. Drenth, Maarten E. Tushuizen, Adriaan G. Holleboom. Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease. Cancers 2023; 15(4): 1308 doi: 10.3390/cancers15041308
|
| 30 |
Sindhia Kumari, Arslan Ali, Talat Roome, Anam Razzak, Ayesha Iqbal, Amna Jabbar Siddiqui, Syed Muhammad Zahid Azam, Hafeezullah Shaikh, Hesham R. El-Seedi, Syed Ghulam Musharraf. Metabolomics approach to understand the hepatitis C virus induced hepatocellular carcinoma using LC-ESI-MS/MS. Arabian Journal of Chemistry 2021; 14(1): 102907 doi: 10.1016/j.arabjc.2020.11.013
|
| 31 |
Jiamei Luo, Teng Wang, Xiaoqiang Wang, Yumiao Shi, Yiqi Zhang, Jie Tian, Yin Gong. Ficolin-3 may act as a tumour suppressor by recognising O-GlcNAcylation site in hepatocellular carcinoma. Medical Hypotheses 2022; 166: 110899 doi: 10.1016/j.mehy.2022.110899
|
| 32 |
Mengmeng Wang, Xiongjun Yang, Yajun Meng, Ze Jin, Jiali Cao, Lina Xiong, Zhifan Xiong. Comprehensive analysis of the tumor-promoting effect and immune infiltration correlation MAZ from pan-cancer to hepatocellular carcinoma. International Immunopharmacology 2023; 115: 109660 doi: 10.1016/j.intimp.2022.109660
|
| 33 |
Yilin Tian, Jing Lu, Yongxia Qiao. A metabolism-associated gene signature for prognosis prediction of hepatocellular carcinoma. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.988323
|
| 34 |
Tahereh Tajik, Kaveh Baghaei, Vahid Erfani Moghadam, Naser Farrokhi, Seyed Alireza Salami. Extracellular vesicles of cannabis with high CBD content induce anticancer signaling in human hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2022; 152: 113209 doi: 10.1016/j.biopha.2022.113209
|
| 35 |
Hu Li, Pengbo Hu, Yajun Zou, Lijuan Yuan, Yucheng Xu, Xiaohui Zhang, Xiaoyan Luo, Zhiqiang Zhang. Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1071415
|
| 36 |
Xinxin Chen, Jin Li, Yuhong Huang, Chao Liang. . Interdisciplinary Cancer Research 2023; doi: 10.1007/16833_2022_110
|
| 37 |
Yating Xu, Xiao Yu, Zongzong Sun, Yuting He, Wenzhi Guo. Roles of lncRNAs Mediating Wnt/β-Catenin Signaling in HCC. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.831366
|
| 38 |
Song Gao, Xingyue Jiang, Liang Wang, Shanshan Jiang, Hanyuan Luo, Yan Chen, Cheng Peng. The pathogenesis of liver cancer and the therapeutic potential of bioactive substances. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1029601
|
| 39 |
Jianhua Wu, Xueting Ren, Nan Wang, Ruina Zhou, Mengsha Chen, Yifan Cai, Shuai Lin, Hao Zhang, Xin Xie, Chengxue Dang, Shuqun Zhang, Zhangjian Zhou. A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.779554
|
| 40 |
Jingyu Xiao, Fei Wang, Xiaoyan Hu, Dongli Li, Geng Liu, Qumiao Xu, Chao Chen, Haitao Xiang, Xuan Dong, Linnan Zhu, Dishuang Yang, Yanan Gao, Meijuan Wang, Yonglun Luo, Cheng‐Chi Chao, Guanglei Li, Qiongyu Guo. Engineering In Vitro Organ‐Structured Tumor Model for Evaluating Neoantigen‐Specific T Cell Responses in Hepatocellular Carcinoma. Advanced Materials Interfaces 2023; 10(24) doi: 10.1002/admi.202300155
|
| 41 |
Bilal Rah, Nada Mazen Farhat, Mawieh Hamad, Jibran Sualeh Muhammad. JAK/STAT signaling and cellular iron metabolism in hepatocellular carcinoma: therapeutic implications. Clinical and Experimental Medicine 2023; doi: 10.1007/s10238-023-01047-8
|
| 42 |
Francisco D. Rodriguez, Rafael Coveñas. Biochemical Mechanisms Associating Alcohol Use Disorders with Cancers. Cancers 2021; 13(14): 3548 doi: 10.3390/cancers13143548
|
| 43 |
Gaoxiang Li, Yazhi Qian, Yuzhu Chen, Mingyue Cao, Xiaozhou Yang, Dexin Kong, Guiping Wang, Haiyan An, Nan Yang, Wei Huang, Yanyong Liu. Wip1 contributes to the adaptation of HepG2 human liver cancer cells to stress hormone‑induced DNA damage. Oncology Letters 2022; 25(1) doi: 10.3892/ol.2022.13617
|
| 44 |
Nehal M. Elsherbiny, Nada H. Eisa, Mohamed El-Sherbiny, Eman Said. Chemo-preventive effect of crocin against experimentally-induced hepatocarcinogenesis via regulation of apoptotic and Nrf2 signaling pathways. Environmental Toxicology and Pharmacology 2020; 80: 103494 doi: 10.1016/j.etap.2020.103494
|
| 45 |
Ye Xu, Qinglong Guo, Libin Wei. The Emerging Influences of Alpha-Fetoprotein in the Tumorigenesis and Progression of Hepatocellular Carcinoma. Cancers 2021; 13(20): 5096 doi: 10.3390/cancers13205096
|
| 46 |
Dafeng Xu, Yu Wang, Jincai Wu, Shixun Lin, Yonghai Chen, Jinfang Zheng. Identification and clinical validation of EMT-associated prognostic features based on hepatocellular carcinoma. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02326-8
|
| 47 |
Peng Zhu, Yongyan Pei, Jian Yu, Wenbin Ding, Yun Yang, Fuchen Liu, Lei Liu, Jian Huang, Shengxian Yuan, Zongyan Wang, Fangming Gu, Zeya Pan, Jinzhong Chen, Jinrong Qiu, Huiying Liu. High-throughput sequencing approach for the identification of lncRNA biomarkers in hepatocellular carcinoma and revealing the effect of ZFAS1/miR-150-5p on hepatocellular carcinoma progression. PeerJ 2023; 11: e14891 doi: 10.7717/peerj.14891
|
| 48 |
Caiqun Bie, Yanfang Chen, Huijun Tang, Qing Li, Lu Zhong, Xiaojuan Peng, Ying Shi, Junqin Lin, Junlong Lai, Shenglan Wu, Shaohui Tang. Insulin-Like Growth Factor 1 Receptor Drives Hepatocellular Carcinoma Growth and Invasion by Activating Stat3-Midkine-Stat3 Loop. Digestive Diseases and Sciences 2022; 67(2): 569 doi: 10.1007/s10620-021-06862-1
|
| 49 |
Kalyani Patil, Said Dermime, Shahab Uddin. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 301 doi: 10.1016/B978-0-323-99283-1.00016-1
|
| 50 |
Hara Afaloniati, Katerina Angelopoulou, Alexander Giakoustidis, Alexandros Hardas, Athanasios Pseftogas, Kali Makedou, Athanasios Gargavanis, Thomas Goulopoulos, Stavros Iliadis, Vasileios Papadopoulos, Apostolos Papalois, George Mosialos, Theofilos Poutahidis, Dimitrios Giakoustidis. <p>HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice</p>. OncoTargets and Therapy 2020; : 5575 doi: 10.2147/OTT.S250233
|
| 51 |
Nan Jiang, Binyan Zhong, Jintao Huang, Wanci Li, Shuai Zhang, Xiaoli Zhu, Caifang Ni, Jian Shen. Transarterial chemoembolization combined with molecularly targeted agents plus immune checkpoint inhibitors for unresectable hepatocellular carcinoma: a retrospective cohort study. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1205636
|
| 52 |
Hong Zhao, Yujie Wang, Yufeng Liu, Xiaohua Hao, Hongshan Wei, Wen Xie. The Effect of Protein FAM172A on Proliferation in HepG2 Cells and Investigation of the Possible Molecular Mechanism. Analytical Cellular Pathology 2019; 2019: 1 doi: 10.1155/2019/5901083
|
| 53 |
Pinar Erkekoglu, Suna Sabuncuoğlu. Liver Cancer in the Middle East. 2021; : 31 doi: 10.1007/978-3-030-78737-0_3
|
| 54 |
Michele Dal Bo, Elena De Mattia, Lorena Baboci, Silvia Mezzalira, Erika Cecchin, Yehuda G. Assaraf, Giuseppe Toffoli. New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma. Drug Resistance Updates 2020; 51: 100702 doi: 10.1016/j.drup.2020.100702
|
| 55 |
Xingyun Wu, Zihao Wang, Li Luo, Dan Shu, Kui Wang. Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine. Frontiers in Medical Technology 2023; 4 doi: 10.3389/fmedt.2022.1065506
|
| 56 |
Sanjit Boora, Vikrant Sharma, Sulochana Kaushik, Ajoy Varma Bhupatiraju, Sandeep Singh, Samander Kaushik. Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem. Brazilian Journal of Microbiology 2023; 54(2): 679 doi: 10.1007/s42770-023-00970-y
|
| 57 |
Payal Deepak, Praveen Kumar, Dilip Kumar Arya, Prashant Pandey, Shiv Kumar, Bishnu Prasad Parida, Gopeshwar Narayan, Sanjay Singh, Paruvathanahalli Siddalingam Rajinikanth. c(RGDfK) anchored surface manipulated liposome for tumor-targeted tyrosine kinase inhibitor (TKI) delivery to potentiate liver anticancer activity. International Journal of Pharmaceutics 2023; 642: 123160 doi: 10.1016/j.ijpharm.2023.123160
|
| 58 |
Huangru Xu, Ping Li, Xiaoyang Wang, Hongqin Zhuang, Zi-Chun Hua. Emerging roles of hnRNP A2B1 in cancer and inflammation. International Journal of Biological Macromolecules 2022; 221: 1077 doi: 10.1016/j.ijbiomac.2022.09.104
|
| 59 |
Mariam Mroweh, Thomas Decaens, Patrice N Marche, Zuzana Macek Jilkova, Flora Clément. Modulating the Crosstalk between the Tumor and Its Microenvironment Using RNA Interference: A Treatment Strategy for Hepatocellular Carcinoma. International Journal of Molecular Sciences 2020; 21(15): 5250 doi: 10.3390/ijms21155250
|
| 60 |
Ning Dimin, Deng Zhe, Wu Yongrong, Mei Si, Teng Yongjie, Zhou Qing, Tian Xuefei. Niuhuang (Bovis Calculus)-Shexiang (Moschus) combination induces apoptosis and inhibits proliferation in hepatocellular carcinoma via PI3K/AKT/mTOR pathway. Digital Chinese Medicine 2022; 5(1): 83 doi: 10.1016/j.dcmed.2022.03.009
|
| 61 |
Yonggui Zhang, Xuefeng Jiang, Xiangjun Li, Mihnea-Alexandru Găman, Hamed Kord-Varkaneh, Jamal Rahmani, Ammar Salehi-Sahlabadi, Andrew S Day, Yan Xu. Serum Vitamin D Levels and Risk of Liver Cancer: A Systematic Review and Dose-Response Meta-Analysis of Cohort Studies. Nutrition and Cancer 2021; 73(8): 1 doi: 10.1080/01635581.2020.1797127
|
| 62 |
Ahmad Khan, Xiaobo Zhang. Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials. Bioengineering 2022; 9(8): 406 doi: 10.3390/bioengineering9080406
|
| 63 |
Ji Hoon Jung, Hyo-Jung Lee, Ju-Ha Kim, Deok Yong Sim, Eunji Im, Sinae Kim, Suhwan Chang, Sung-Hoon Kim. Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2. Cells 2020; 9(4): 985 doi: 10.3390/cells9040985
|
| 64 |
Zhenzhen Su, Limei Luo, Xiaojuan Wu, Bin Wei, Lu Wang, Fei Liu, Bei Cai. Association of the MARCO polymorphism rs6761637 with hepatocellular carcinoma susceptibility and clinical characteristics. Immunologic Research 2022; 70(3): 400 doi: 10.1007/s12026-022-09271-2
|
| 65 |
Zhicheng Yao, Ruiyun Xu, Lin Yuan, Mingxing Xu, Haiyun Zhuang, Yanjie Li, Yi Zhang, Nan Lin. Circ_0001955 facilitates hepatocellular carcinoma (HCC) tumorigenesis by sponging miR-516a-5p to release TRAF6 and MAPK11. Cell Death & Disease 2019; 10(12) doi: 10.1038/s41419-019-2176-y
|
| 66 |
Bao-Kang Wu, Qian-Hui Chen, Dan Pan, Bing Chang, Li-Xuan Sang. A novel therapeutic strategy for hepatocellular carcinoma: Immunomodulatory mechanisms of selenium and/or selenoproteins on a shift towards anti-cancer. International Immunopharmacology 2021; 96: 107790 doi: 10.1016/j.intimp.2021.107790
|
| 67 |
Anna Buttell, Wei Qiu. The action and resistance mechanisms of Lenvatinib in liver cancer. Molecular Carcinogenesis 2023; doi: 10.1002/mc.23625
|
| 68 |
Yu Jin Kim, Nayeong Yuk, Hee Jeong Shin, Hye Jin Jung. The Natural Pigment Violacein Potentially Suppresses the Proliferation and Stemness of Hepatocellular Carcinoma Cells In Vitro. International Journal of Molecular Sciences 2021; 22(19): 10731 doi: 10.3390/ijms221910731
|
| 69 |
Lin Xing, Yuting Tang, Lu Li, Xufeng Tao. ROS in hepatocellular carcinoma: What we know. Archives of Biochemistry and Biophysics 2023; 744: 109699 doi: 10.1016/j.abb.2023.109699
|
| 70 |
Ilaria Chiodi, Chiara Mondello. Life style factors, tumor cell plasticity and cancer stem cells. Mutation Research/Reviews in Mutation Research 2020; 784: 108308 doi: 10.1016/j.mrrev.2020.108308
|
| 71 |
Qicong Mai, Dafeng Sheng, Chengcong Chen, Qing Gou, Meng Chen, Xiaoting Huang, Heng Yin, Xiaoming Chen, Zide Chen. Steroid 5 alpha-reductase 3 (SRD5A3) promotes tumor growth and predicts poor survival of human hepatocellular carcinoma (HCC). Aging 2020; 12(24): 25395 doi: 10.18632/aging.104142
|
| 72 |
Julie Pellegrinelli, Olivier Chevallier, Sylvain Manfredi, Inna Dygai-Cochet, Claire Tabouret-Viaud, Guillaume Nodari, François Ghiringhelli, Jean-Marc Riedinger, Romain Popoff, Jean-Marc Vrigneaud, Alexandre Cochet, Serge Aho, Marianne Latournerie, Romaric Loffroy. Transarterial Radioembolization of Hepatocellular Carcinoma, Liver-Dominant Hepatic Colorectal Cancer Metastases, and Cholangiocarcinoma Using Yttrium90 Microspheres: Eight-Year Single-Center Real-Life Experience. Diagnostics 2021; 11(1): 122 doi: 10.3390/diagnostics11010122
|
| 73 |
Xiufen Zhang, Sui Xu, Caixia Hu, Kai Fang, Junjing Zhou, Zijian Guo, Guoding Zhu, Lihua Li. LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma progression by regulating MAGEA3 and DCAF4L2 expression. Biochemical and Biophysical Research Communications 2020; 533(4): 1039 doi: 10.1016/j.bbrc.2020.09.115
|
| 74 |
Jie Chen, Xicheng Wang, Xining Wang, Wenxin Li, Changzhen Shang, Tao Chen, Yajin Chen. A FITM1-Related Methylation Signature Predicts the Prognosis of Patients With Non-Viral Hepatocellular Carcinoma. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00099
|
| 75 |
Anna Rossetto, Valli De Re, Agostino Steffan, Matteo Ravaioli, Gianmaria Miolo, Patrizia Leone, Vito Racanelli, Alessandro Uzzau, Umberto Baccarani, Matteo Cescon. Carcinogenesis and Metastasis in Liver: Cell Physiological Basis. Cancers 2019; 11(11): 1731 doi: 10.3390/cancers11111731
|
| 76 |
Giulia Orsi, Francesco Tovoli, Vincenzo Dadduzio, Caterina Vivaldi, Oronzo Brunetti, Luca Ielasi, Fabio Conti, Giulia Rovesti, Laura Gramantieri, Mario Domenico Rizzato, Irene Pecora, Antonella Argentiero, Federica Teglia, Sara Lonardi, Francesca Salani, Alessandro Granito, Vittorina Zagonel, Giorgia Marisi, Giuseppe Cabibbo, Francesco Giuseppe Foschi, Francesca Benevento, Alessandro Cucchetti, Fabio Piscaglia, Stefano Cascinu, Mario Scartozzi, Andrea Casadei-Gardini. Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma. Targeted Oncology 2020; 15(6): 773 doi: 10.1007/s11523-020-00757-3
|
| 77 |
Francesca V. LoBianco, Kimberly J. Krager, Erica Johnson, Christopher O. Godwin, Antino R. Allen, Peter A. Crooks, Cesar M. Compadre, Michael J. Borrelli, Nukhet Aykin-Burns. Parthenolide induces rapid thiol oxidation that leads to ferroptosis in hepatocellular carcinoma cells. Frontiers in Toxicology 2022; 4 doi: 10.3389/ftox.2022.936149
|
| 78 |
Yipeng Zhang, Lijun Li, Renzhi Liu, Changchun Zeng. DNA Primase Subunit 1 Expression in Hepatocellular Carcinoma and Its Clinical Implication. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/9689312
|
| 79 |
Muhammed Mehdi Üremiş, Nuray Üremiş, Emir Tosun, Merve Durhan, Yılmaz Çiğremiş, Ahmet Baysar, Yusuf Türköz. Cucurbitacin D Inhibits the Proliferation of HepG2 Cells and Induces
Apoptosis by Modulating JAK/STAT3, PI3K/Akt/mTOR and MAPK Signaling
Pathways. Current Cancer Drug Targets 2022; 22(11): 931 doi: 10.2174/1568009622666220623141158
|
| 80 |
Wu Xing, Peng‐Cheng Zhou, Hao‐Ye Zhang, Li‐Min Chen, Yang‐Mei Zhou, Xue‐Fei Cui, Zhen‐Guo Liu. Circular RNA circ_GLIS2 suppresses hepatocellular carcinoma growth and metastasis. Liver International 2022; 42(3): 682 doi: 10.1111/liv.15097
|
| 81 |
Sanya Batheja, Rakesh Kumar Sahoo, Sofiya Tarannum, Klaudi K. Vaiphei, Shikha Jha, Amit Alexander, Amit Kumar Goyal, Umesh Gupta. Hepatocellular carcinoma: Preclinical and clinical applications of nanotechnology with the potential role of carbohydrate receptors. Biochimica et Biophysica Acta (BBA) - General Subjects 2023; 1867(10): 130443 doi: 10.1016/j.bbagen.2023.130443
|
| 82 |
Dazhi Tian, Yang Yu, Li Zhang, Jisan Sun, Wentao Jiang. 23-hydroxybetulinic acid reduces tumorigenesis, metastasis and immunosuppression in a mouse model of hepatocellular carcinoma via disruption of the MAPK signaling pathway. Anti-Cancer Drugs 2022; 33(9): 815 doi: 10.1097/CAD.0000000000001325
|
| 83 |
Linmeng Han, Chunyu Zhang, Danni Wang, Jiaqi Zhang, Qiqi Tang, Mulin Jun Li, Michael N. Sack, Lingdi Wang, Lu Zhu. Retrograde regulation of mitochondrial fission and epithelial to mesenchymal transition in hepatocellular carcinoma by GCN5L1. Oncogene 2023; 42(13): 1024 doi: 10.1038/s41388-023-02621-w
|
| 84 |
Runjie Song, Shuoqian Ma, Jiajia Xu, Xin Ren, Peilan Guo, Huijiao Liu, Peng Li, Fan Yin, Mei Liu, Qiang Wang, Lei Yu, Jiali Liu, Binwei Duan, Nafis A. Rahman, Sławomir Wołczyński, Guangming Li, Xiangdong Li. A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR. Molecular Cancer 2023; 22(1) doi: 10.1186/s12943-023-01719-9
|
| 85 |
Cho-Won Kim, Hong Kyu Lee, Min-Woo Nam, Youngdong Choi, Kyung-Chul Choi. Overexpression of KiSS1 Induces the Proliferation of Hepatocarcinoma and Increases Metastatic Potential by Increasing Migratory Ability and Angiogenic Capacity. Molecules and Cells 2022; 45(12): 935 doi: 10.14348/molcells.2022.0105
|
| 86 |
Uasim Harkus, Miriam Wankell, Pranavan Palamuthusingam, Craig McFarlane, Lionel Hebbard. Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic data. Seminars in Cancer Biology 2022; 86: 799 doi: 10.1016/j.semcancer.2022.01.005
|
| 87 |
Wei Guan, Wang Qi. Ginsenoside Rh2: A shining and potential natural product in the treatment of human nonmalignant and malignant diseases in the near future. Phytomedicine 2023; 118: 154938 doi: 10.1016/j.phymed.2023.154938
|
| 88 |
Ehab Kotb Elmahallawy, Yasser Mohamed, Walied Abdo, Tokuma Yanai. Melatonin and Mesenchymal Stem Cells as a Key for Functional Integrity for Liver Cancer Treatment. International Journal of Molecular Sciences 2020; 21(12): 4521 doi: 10.3390/ijms21124521
|
| 89 |
Jasem Albarrak, Humaid Al-Shamsi. Current Status of Management of Hepatocellular Carcinoma in The Gulf Region: Challenges and Recommendations. Cancers 2023; 15(7): 2001 doi: 10.3390/cancers15072001
|
| 90 |
Aqsa Nazir, Muhammad Aqib, Muhammad Usman. Liver Cancer - Genesis, Progression and Metastasis. 2023; doi: 10.5772/intechopen.106020
|
| 91 |
Amna Mohamed Taha, Mohammad Mabrouk Aboulwafa, Hamdallah Zedan, Omneya Mohamed Helmy. Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-21582-w
|
| 92 |
Frédéric Geinguenaud, Odile Sainte‐Catherine, Florence Poirier, Valérie Besnard, Oualid Haddad, Frédéric Chaubet, Yoann Lalatonne, Didier Lutomski, Angela Sutton, Laurence Motte. Iron Oxide Nanoparticles Functionalized with Fucoidan: a Potential Theranostic Nanotool for Hepatocellular Carcinoma. ChemBioChem 2022; 23(16) doi: 10.1002/cbic.202200265
|
| 93 |
Aalok Basu, Thanaphon Namporn, Pakatip Ruenraroengsak. Critical Review in Designing Plant-Based Anticancer Nanoparticles against Hepatocellular Carcinoma. Pharmaceutics 2023; 15(6): 1611 doi: 10.3390/pharmaceutics15061611
|
| 94 |
Jade Cochard, Anne Bull‐Maurer, Clovis Tauber, Julien Burlaud‐Gaillard, Frédéric Mazurier, Jean‐Christophe Meunier, Philippe Roingeard, Philippe Chouteau. Differentiated Cells in Prolonged Hypoxia Produce Highly Infectious Native‐Like Hepatitis C Virus Particles. Hepatology 2021; 74(2): 627 doi: 10.1002/hep.31788
|
| 95 |
Ann Abd-Almonem Farid, Nermin Abd-Almaksoud Afify, Aml Abd-Alhamid Alsharnoby, Eman Abdelsameea, Hanan M. Bedair. Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma. Immunological Investigations 2022; 51(5): 1211 doi: 10.1080/08820139.2021.1920609
|
| 96 |
Meenakshi Gupta, Shaikh Maryam Ghufran, Tasneem Kausar, Rafat Ali, Subhrajit Biswas, Shahid M. Nayeem, Romana Ishrat, Sher Ali, Ajaz Ahmad, Irfan A. Rather, Maryam Sarwat. Z-Guggulsterone Is a Potential Lead Molecule of Dawa-ul-Kurkum against Hepatocellular Carcinoma. Molecules 2022; 27(16): 5104 doi: 10.3390/molecules27165104
|
| 97 |
Naima Zayed Mohamed, Hanan Farouk Aly, Hatem Abdel moneim El-Mezayen, Hadeer E. El-Salamony. Effect of co-administration of Bee honey and some chemotherapeutic drugs on dissemination of hepatocellular carcinoma in rats. Toxicology Reports 2019; 6: 875 doi: 10.1016/j.toxrep.2019.08.007
|
| 98 |
Ping Chen, Xiaomeng Liu, Yayue Liu, Xu Bao, Qiang Wu. ARHGAP18 is Upregulated by Transcription Factor GATA1 Promotes the Proliferation and Invasion in Hepatocellular Carcinoma. Applied Biochemistry and Biotechnology 2023; doi: 10.1007/s12010-023-04459-0
|
| 99 |
Zehra Omeroglu Ulu, Zeynep Busra Bolat, Fikrettin Sahin. Integrated transcriptome and in vitro analysis revealed anti-proliferative effect of sodium perborate on hepatocellular carcinoma cells. Journal of Trace Elements in Medicine and Biology 2022; 73: 127011 doi: 10.1016/j.jtemb.2022.127011
|
| 100 |
Jie Kong, Tingfeng Huang, Jianxi Zhang, Shichuan Tang, Hongzhi Liu, Jingfeng Liu, Yongyi Zeng. Analysis of conditional survival in primary hepatocellular carcinoma after narrow-margin hepatectomy: a large-sample, dual-centre, retrospective study. HPB 2023; 25(2): 179 doi: 10.1016/j.hpb.2022.08.005
|
| 101 |
Anna Santarsiero, Ilaria Pappalardo, Gabriella Margherita Rosa, Isabella Pisano, Stefano Superchi, Paolo Convertini, Simona Todisco, Patrizia Scafato, Vittoria Infantino. Mitochondrial Role in Intrinsic Apoptosis Induced by a New Synthesized Chalcone in Hepatocellular Carcinoma Cells. Biomedicines 2022; 10(12): 3120 doi: 10.3390/biomedicines10123120
|
| 102 |
Davide Ippolito, Cesare Maino, Marco Gatti, Paolo Marra, Riccardo Faletti, Francesco Cortese, Riccardo Inchingolo, Sandro Sironi. Radiological findings in non-surgical recurrent hepatocellular carcinoma: From locoregional treatments to immunotherapy. World Journal of Gastroenterology 2023; 29(11): 1669-1684 doi: 10.3748/wjg.v29.i11.1669
Abstract(201) |
Core Tip(158) |
Full Article(HTML)(709)
|
Full Article (PDF)-6726K(102)
|
Full Article (Word)-1946K(21)
|
Audio-671K(4)
|
Peer-Review Report-313K(19)
|
Answering Reviewers-73K(15)
|
Times Cited (0)
|
Total Visits (2098)
|
Open
|
| 103 |
Wenyuan Zhang, Chongling Zhang, Shixin Liu, Yongjing Yang. Study on biological activity and p38 mitogen-activated protein kinases of magnetic nanoparticles on hepatoma cells. Materials Express 2023; 13(6): 961 doi: 10.1166/mex.2023.2428
|
| 104 |
Lei Chen, Dafang Zhang, Shengmin Zheng, Xinyu Li, Pengji Gao. Stemness analysis in hepatocellular carcinoma identifies an extracellular matrix gene–related signature associated with prognosis and therapy response. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.959834
|
| 105 |
Maryam Ranjpour, Saima Wajid, Swatantra Kumar Jain. Elevated expression of sepiapterin reductase, regulator of G protein signaling 1, hypothetical protein CXorf58 homolog, and zinc finger and BTB domain–containing protein 21 isoform X2 is associated with progression of hepatocellular carcinoma. Protoplasma 2021; 258(5): 1133 doi: 10.1007/s00709-021-01632-2
|
| 106 |
Yan Su, Ruizhu Xie, Qinyan Xu. LncRNA THAP9-AS1 highly expressed in tissues of hepatocellular carcinoma and accelerates tumor cell proliferation. Clinics and Research in Hepatology and Gastroenterology 2022; 46(10): 102025 doi: 10.1016/j.clinre.2022.102025
|
| 107 |
Yun Zhang, Li Shen, Bojun Wang, Xiaohong Wu. Ethanolamine-phosphate phospho-lyase (ETNPPL) contributes to the diagnosis, prognosis, and therapy of hepatocellular carcinoma. PeerJ 2023; 11: e15834 doi: 10.7717/peerj.15834
|
| 108 |
Yilihamu Maimaiti, Aihesan Kamali, Peng Yang, Kai Zhong, Xiaokaiti Abuduhadeer. Hsa_circ_0008092 Contributes to Cell Proliferation and Metastasis in
Hepatocellular Carcinoma via the miR-502-5p/CCND1 Axis. Protein & Peptide Letters 2022; 29(7): 595 doi: 10.2174/0929866529666220721090209
|
| 109 |
Jeannette Huaman, Olorunseun O. Ogunwobi. Circulating Tumor Cell Migration Requires Fibronectin Acting through Integrin B1 or SLUG. Cells 2020; 9(7): 1594 doi: 10.3390/cells9071594
|
| 110 |
Chengwu Zeng, Wanxu Huang, Yangqiu Li, Hengyou Weng. Roles of METTL3 in cancer: mechanisms and therapeutic targeting. Journal of Hematology & Oncology 2020; 13(1) doi: 10.1186/s13045-020-00951-w
|
| 111 |
Ziqi Meng, Jiarui Wu, Xinkui Liu, Wei Zhou, Mengwei Ni, Shuyu Liu, Siyu Guo, Shanshan Jia, Jingyuan Zhang. Identification of potential hub genes associated with the pathogenesis and prognosis of hepatocellular carcinoma via integrated bioinformatics analysis. Journal of International Medical Research 2020; 48(7): 030006052091001 doi: 10.1177/0300060520910019
|
| 112 |
Zhiwei Shao, Haoqi Pan, Sheng Tu, Jingying Zhang, Sheng Yan, Anwen Shao. HGF/c-Met Axis: The Advanced Development in Digestive System Cancer. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00801
|
| 113 |
Yu Gan, Weidan Fang, Yan Zeng, Peijun Wang, Renfeng Shan, Ling Zhang. Identification of a Novel Survival-Related circRNA–miRNA–mRNA Regulatory Network Related to Immune Infiltration in Liver Hepatocellular Carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.800537
|
| 114 |
Jeannette Huaman, Michelle Naidoo, Xingxing Zang, Olorunseun O. Ogunwobi. Fibronectin Regulation of Integrin B1 and SLUG in Circulating Tumor Cells. Cells 2019; 8(6): 618 doi: 10.3390/cells8060618
|
| 115 |
Kenya Kamimura, Takeshi Yokoo, Hiroyuki Abe, Shuji Terai. Gene Therapy for Liver Cancers: Current Status from Basic to Clinics. Cancers 2019; 11(12): 1865 doi: 10.3390/cancers11121865
|
| 116 |
Huijie Zhao, Yiming Zhang, Yanting Zhang, Chaoran Chen, Huiyang Liu, Yihan Yang, Honggang Wang. The role of NLRP3 inflammasome in hepatocellular carcinoma. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1150325
|
| 117 |
Yaser E. Alqurashi, Hussein Riyadh Abdul Kareem Al-Hetty, Pushpamala Ramaiah, Alaa Hameed Fazaa, Abduladheem Turki Jalil, Fahad Alsaikhan, Jitendra Gupta, Andrés Alexis Ramírez-Coronel, Nahla A. Tayyib, Hu Peng. Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint. Environmental Research 2023; 227: 115683 doi: 10.1016/j.envres.2023.115683
|
| 118 |
Yang Yang, Qi Mei. Accumulation of AGO2 Facilitates Tumorigenesis of Human Hepatocellular Carcinoma. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/1631843
|